Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0TPQUN
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
9MW-2821
|
|||||
| Synonyms |
9MW 2821; 9MW-2821; 9MW2821
Click to Show/Hide
|
|||||
| Organization |
Jiangsu Maiweikang New Drug R & D Co., Ltd.; Mabwell (Shanghai) Bioscience Co., Ltd.
|
|||||
| Drug Status |
Phase 1/2
|
|||||
| Indication |
In total 3 Indication(s)
|
|||||
| Drug-to-Antibody Ratio |
4
|
|||||
| Structure |
|
|||||
| Antibody Name |
Bulumtatug
|
Antibody Info | ||||
| Antigen Name |
Nectin-4 (NECTIN4)
|
Antigen Info | ||||
| Payload Name |
Monomethyl auristatin E
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
IDM-Val-Cit-PBCA
|
Linker Info | ||||
| Conjugate Type |
Reactive Cysteines
|
|||||
| Combination Type |
fuvedotin
|
|||||
